Sotirios Stergiopoulos

Dr. Sotirios G.
Stergiopoulos, MD, is a President & Chief Executive Officer at A2a Pharmaceuticals, Inc. and an Executive Chairman at Coiled Therapeutics Plc.
He is on the Board of Directors at Ricovr Healthcare, Inc. Dr. Stergiopoulos was previously employed as an Independent Director by Biomea Fusion, Inc., a Chief Medical Officer & Senior Vice President by Ipsen Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by Ipsen SA, a Vice President & Head-Global Medical Affairs by Baxalta, Inc., a Vice President & Head-Global Medical Affairs by Shire Plc, an Executive Director-US Medical Affairs Oncology by Celgene Corp., a Senior Director-Global Brand Medical by Novartis AG, and a Deputy Director-Global Medical Affairs Oncology by Bayer Healthcare LLC.
He received his undergraduate degree from Stony Brook University, a graduate degree from The Johns Hopkins University and a doctorate degree from Poznan University of Medical Science.